Figure 1.
Overall efficacy of 15 mg/d tolvaptan. Overall efficacy of 15 mg/d tolvaptan for 5-14 d in all patients as well as in subgroups of patients with coexisting hepatocellular carcinoma (HCC) and hepatorenal syndrome (HRS) post-tolvaptan treatment.